HRP20190245T1 - Tartratna sol [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metil piperazin-1 -il)-3-okso-propril]amida 5-kloro-tiofen-2-karboksilne kiseline - Google Patents
Tartratna sol [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metil piperazin-1 -il)-3-okso-propril]amida 5-kloro-tiofen-2-karboksilne kiselineInfo
- Publication number
- HRP20190245T1 HRP20190245T1 HRP20190245TT HRP20190245T HRP20190245T1 HR P20190245 T1 HRP20190245 T1 HR P20190245T1 HR P20190245T T HRP20190245T T HR P20190245TT HR P20190245 T HRP20190245 T HR P20190245T HR P20190245 T1 HRP20190245 T1 HR P20190245T1
- Authority
- HR
- Croatia
- Prior art keywords
- oxo
- methyl
- propryl
- benzenesulfonylamino
- pyrrolidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13305556 | 2013-04-26 | ||
| EP14719340.3A EP2989095B1 (en) | 2013-04-26 | 2014-04-25 | Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide |
| PCT/EP2014/058513 WO2014174102A1 (en) | 2013-04-26 | 2014-04-25 | Tartrate salt of 5-chloro-thiophene-2-carboxylic acid [(s)-2-[methyl-3-(2-oxo-pyrrolidin-1-yl)-benzenesulfonylamino]-3-(4-methyl piperazin-1 -yl)-3-oxo-propryl]amide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190245T1 true HRP20190245T1 (hr) | 2019-04-05 |
Family
ID=48428407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190245TT HRP20190245T1 (hr) | 2013-04-26 | 2019-02-06 | Tartratna sol [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metil piperazin-1 -il)-3-okso-propril]amida 5-kloro-tiofen-2-karboksilne kiseline |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9637479B2 (hr) |
| EP (1) | EP2989095B1 (hr) |
| JP (1) | JP6393310B2 (hr) |
| KR (1) | KR102388926B1 (hr) |
| CN (1) | CN105143213B (hr) |
| AU (1) | AU2014259378B2 (hr) |
| BR (1) | BR112015026841A8 (hr) |
| CA (1) | CA2910085C (hr) |
| CY (1) | CY1123536T1 (hr) |
| DK (1) | DK2989095T3 (hr) |
| ES (1) | ES2711144T3 (hr) |
| HR (1) | HRP20190245T1 (hr) |
| HU (1) | HUE042250T2 (hr) |
| IL (1) | IL242081B (hr) |
| LT (1) | LT2989095T (hr) |
| MX (1) | MX360896B (hr) |
| PL (1) | PL2989095T3 (hr) |
| PT (1) | PT2989095T (hr) |
| RU (1) | RU2664538C2 (hr) |
| SG (1) | SG11201508515WA (hr) |
| SI (1) | SI2989095T1 (hr) |
| TR (1) | TR201901931T4 (hr) |
| TW (1) | TWI615390B (hr) |
| WO (1) | WO2014174102A1 (hr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022338082A1 (en) | 2021-09-03 | 2024-02-15 | Bayer Aktiengesellschaft | Substituted s-alaninate derivatives |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0778835A4 (en) * | 1994-08-25 | 1999-02-03 | Univ Virginia | 7-AZABICYCLO (2.2.1) -HEPTANE AND -HEPTENE DERIVATIVES AS LIGANDS OF THE CHOLI ENERGY RECEPTORS |
| JP4160634B2 (ja) * | 1996-05-31 | 2008-10-01 | シグマ―タウ インダストゥリー ファーマチェウティケ リウニーテ ソシエタ ペル アチオニ | Ｌ（―）カルニチンおよびアルカノイルｌ（―）カルニチン類の安定な非吸湿性塩、それらの製造方法並びに該塩を含有する固形の経口投与可能な組成物 |
| SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
| GB0114005D0 (en) * | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| GB0127568D0 (en) * | 2001-11-16 | 2002-01-09 | Glaxo Group Ltd | Chemical compounds |
| GB0228552D0 (en) * | 2002-12-06 | 2003-01-15 | Glaxo Group Ltd | Chemical compounds |
| CA2537170A1 (en) * | 2003-08-28 | 2005-03-10 | Mayne Pharma Pty Ltd | Acid containing oxaliplatin formulations |
| US7371743B2 (en) * | 2004-02-28 | 2008-05-13 | Boehringer Ingelheim International Gmbh | Carboxylic acid amides, the preparation thereof and their use as medicaments |
| JP5422570B2 (ja) * | 2008-02-21 | 2014-02-19 | サノフイ | 凝固第Ｘａ因子及びトロンビンの阻害剤としてのクロロチオフェン−アミド類 |
| KR100953535B1 (ko) * | 2008-07-17 | 2010-04-21 | 재단법인 포항산업과학연구원 | 염소계 화합물을 이용한 배가스 내 수은 제거 방법 |
-
2014
- 2014-04-25 SG SG11201508515WA patent/SG11201508515WA/en unknown
- 2014-04-25 RU RU2015150388A patent/RU2664538C2/ru active
- 2014-04-25 TR TR2019/01931T patent/TR201901931T4/tr unknown
- 2014-04-25 HU HUE14719340A patent/HUE042250T2/hu unknown
- 2014-04-25 DK DK14719340.3T patent/DK2989095T3/en active
- 2014-04-25 LT LTEP14719340.3T patent/LT2989095T/lt unknown
- 2014-04-25 KR KR1020157032913A patent/KR102388926B1/ko active IP Right Grant
- 2014-04-25 EP EP14719340.3A patent/EP2989095B1/en active Active
- 2014-04-25 MX MX2015014986A patent/MX360896B/es active IP Right Grant
- 2014-04-25 CA CA2910085A patent/CA2910085C/en active Active
- 2014-04-25 WO PCT/EP2014/058513 patent/WO2014174102A1/en active Application Filing
- 2014-04-25 TW TW103115126A patent/TWI615390B/zh active
- 2014-04-25 JP JP2016509496A patent/JP6393310B2/ja active Active
- 2014-04-25 PL PL14719340T patent/PL2989095T3/pl unknown
- 2014-04-25 CN CN201480023265.1A patent/CN105143213B/zh active Active
- 2014-04-25 ES ES14719340T patent/ES2711144T3/es active Active
- 2014-04-25 AU AU2014259378A patent/AU2014259378B2/en active Active
- 2014-04-25 SI SI201431086T patent/SI2989095T1/sl unknown
- 2014-04-25 US US14/786,953 patent/US9637479B2/en active Active
- 2014-04-25 BR BR112015026841A patent/BR112015026841A8/pt not_active Application Discontinuation
- 2014-04-25 PT PT14719340T patent/PT2989095T/pt unknown
-
2015
- 2015-10-14 IL IL242081A patent/IL242081B/en active IP Right Grant
-
2019
- 2019-02-06 HR HRP20190245TT patent/HRP20190245T1/hr unknown
- 2019-02-20 CY CY20191100216T patent/CY1123536T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200010I1 (hu) | Kondenzált heterociklusos vegyületek protein-kináz inhibitorként | |
| HRP20201107T8 (hr) | Heteroaril amidi kao inhibitori proteinske agregacije | |
| HK1221606A1 (zh) | 纖維化的小分子抑制劑 | |
| ZA201502783B (en) | Azaquinazoline inhibitors of atypical protein kinase c | |
| IL242239B (en) | Co-crystals of dapagliflozin | |
| SG11201507347QA (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| SG11201507358VA (en) | Pharmaceutical composition of s-ketamine hydrochloride | |
| EP2968321A4 (en) | COMPOUNDS FOR THE TREATMENT OF FIBROSIS DISEASES | |
| HK1204559A1 (en) | Solid composition of amino carboxylate salt | |
| PL3063152T3 (pl) | Dogodne wytwarzanie n-podstawionych morfinan-6-oli z morfinan-6-onów | |
| HRP20190245T1 (hr) | Tartratna sol [(s)-2-[metil-3-(2-okso-pirolidin-1-il)-benzensulfonilamino]-3-(4-metil piperazin-1 -il)-3-okso-propril]amida 5-kloro-tiofen-2-karboksilne kiseline |